• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带佐剂的杜氏利什曼原虫全细胞抗原可保护黑长尾猴(埃塞俄比亚绿猴)免受内脏利什曼病的侵害。

Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).

作者信息

Mutiso Joshua Muli, Macharia John Chege, Taracha Evans, Gicheru Michael Muita

机构信息

Department of Tropical and Infectious Diseases, Institute of Primate Research, Karen, Nairobi 24481-00502, Kenya; ; Department of Zoological Sciences, Kenyatta University, Nairobi 43844-00100, Kenya.

出版信息

J Biomed Res. 2012 Jan;26(1):8-16. doi: 10.1016/S1674-8301(12)60002-5.

DOI:10.1016/S1674-8301(12)60002-5
PMID:23554725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3596075/
Abstract

In a previous immunogenicity and efficacy study in mice, montanide ISA 720 (MISA) was indicated to be a better adjuvant than bacillus calmette guerin vaccine (BCG) for a Leishmania vaccine. In the present study, we report the safety, immunogenicity and efficacy of Leishmania donovani (L. donovani) sonicated antigen delivered with alum-BCG (AlBCG), MISA or monophosphoryl lipid A (MPLA) in vervet monkeys following intradermal inoculums. Vaccinated and control animals were challenged with virulent L. donovani parasites and the parasitic burden was determined. Only animals vaccinated with alum-BCG adversely reacted to the inoculum by producing ulcerative erythematous skin indurations. Non-parametric ANOVA followed by a post test showed significantly higher IgG antibodies, and revealed the presence of lymphoproliferative and interferon gamma responses in both AlBCG+Ag and MISA+Ag as compared to the MPLA+Ag or other groups (P < 0.001). We conclude that L. donovani sonicated antigen containing MISA is safe and is associated with protective immune response against Leishmania donovani infection in the vervet monkey model.

摘要

在之前一项针对小鼠的免疫原性和功效研究中,对于利什曼原虫疫苗而言,Montanide ISA 720(MISA)被证明是比卡介苗(BCG)更好的佐剂。在本研究中,我们报告了在黑长尾猴皮内接种含铝卡介苗(AlBCG)、MISA或单磷酰脂质A(MPLA)的杜氏利什曼原虫(L. donovani)超声抗原后的安全性、免疫原性和功效。对接种疫苗的动物和对照动物用强毒力的杜氏利什曼原虫寄生虫进行攻击,并测定寄生虫负荷。只有接种含铝卡介苗的动物对接种物产生了溃疡性红斑皮肤硬结的不良反应。非参数方差分析及后续检验显示,与MPLA+抗原组或其他组相比,AlBCG+抗原组和MISA+抗原组的IgG抗体显著更高,且存在淋巴细胞增殖和干扰素γ反应(P < 0.001)。我们得出结论,含MISA的杜氏利什曼原虫超声抗原是安全的,并且在黑长尾猴模型中与针对杜氏利什曼原虫感染的保护性免疫反应相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/971e5da5a850/jbr-26-01-008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/0a01f83e870a/jbr-26-01-008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/f560ae310f73/jbr-26-01-008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/602f388e3a80/jbr-26-01-008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/971e5da5a850/jbr-26-01-008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/0a01f83e870a/jbr-26-01-008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/f560ae310f73/jbr-26-01-008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/602f388e3a80/jbr-26-01-008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2434/3596075/971e5da5a850/jbr-26-01-008-g004.jpg

相似文献

1
Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).携带佐剂的杜氏利什曼原虫全细胞抗原可保护黑长尾猴(埃塞俄比亚绿猴)免受内脏利什曼病的侵害。
J Biomed Res. 2012 Jan;26(1):8-16. doi: 10.1016/S1674-8301(12)60002-5.
2
Safety and skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants.用佐剂递送的杜氏利什曼原虫超声破碎抗原免疫黑长尾猴后的安全性及皮肤迟发型超敏反应
Rev Inst Med Trop Sao Paulo. 2012 Jan-Feb;54(1):37-41. doi: 10.1590/s0036-46652012000100007.
3
Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model.用利什曼原虫疫苗-明矾-BCG 和 Montanide ISA 720 佐剂免疫恒河猴(Chlorocebus aethiops)模型可诱导低水平的 2 型细胞因子和高水平的 IgG2 亚类抗体。
Scand J Immunol. 2012 Nov;76(5):471-7. doi: 10.1111/j.1365-3083.2012.02764.x.
4
Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease.在黑长尾猴疾病模型中,杜氏利什曼原虫对硕大利什曼原虫感染的异源保护作用。
Exp Parasitol. 1997 Feb;85(2):109-16. doi: 10.1006/expr.1996.4117.
5
Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG.使用经明矾沉淀、高压灭菌的硕大利什曼原虫与卡介苗对印度叶猴进行杜氏利什曼原虫感染的成功疫苗接种。
Vaccine. 2001 May 14;19(25-26):3485-92. doi: 10.1016/s0264-410x(01)00058-5.
6
Subcutaneous immunization against Leishmania major - infection in mice: efficacy of formalin-killed promastigotes combined with adjuvants.小鼠中针对硕大利什曼原虫感染的皮下免疫:福尔马林灭活前鞭毛体联合佐剂的疗效
Rev Inst Med Trop Sao Paulo. 2010 Mar-Apr;52(2):95-100. doi: 10.1590/s0036-46652010000200006.
7
Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.评价不同佐剂与致死量感染杜氏利什曼原虫抗原联合应用对实验内脏利什曼病的免疫原性和保护效果。
Med Microbiol Immunol. 2015 Aug;204(4):539-50. doi: 10.1007/s00430-014-0367-9. Epub 2014 Nov 29.
8
Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice.用佐剂增强的杜氏利什曼原虫疫苗对 BALB/c 小鼠内脏利什曼病的免疫诱导。
Immunobiology. 2021 Mar;226(2):152057. doi: 10.1016/j.imbio.2021.152057. Epub 2021 Jan 23.
9
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.BCG、MPL 和阳离子脂质体佐剂系统在抗内脏利什曼病的利什曼原虫抗原疫苗配方中的比较。
BMC Microbiol. 2010 Jun 24;10:181. doi: 10.1186/1471-2180-10-181.
10
Visceral leishmaniasis in vervet monkeys: immunological responses during asymptomatic infections.绿猴内脏利什曼病:无症状感染期间的免疫反应。
Scand J Immunol. 1995 Feb;41(2):202-8. doi: 10.1111/j.1365-3083.1995.tb03554.x.

引用本文的文献

1
Safety and Efficacy of Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice.叶提取物作为治疗Balb/c小鼠内脏利什曼病的潜在疗法的安全性和有效性
Iran J Parasitol. 2021 Oct-Dec;16(4):652-662. doi: 10.18502/ijpa.v16i4.7878.
2
Vaccines Entered in Clinical Trials: A Review of Literature.进入临床试验的疫苗:文献综述
Int J Prev Med. 2019 Jun 7;10:95. doi: 10.4103/ijpvm.IJPVM_116_18. eCollection 2019.
3
In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis.

本文引用的文献

1
Mitogenic responses of peripheral blood mononuclear cells of vervet monkeys (Cercopithecus aethiops): Apparent role of adherent cells.绿猴(猕猴)外周血单个核细胞的促有丝分裂反应:贴壁细胞的明显作用。
Am J Primatol. 1990;20(1):31-36. doi: 10.1002/ajp.1350200105.
2
A review of adjuvants for Leishmania vaccine candidates.利什曼原虫疫苗候选佐剂综述。
J Biomed Res. 2010 Jan;24(1):16-25. doi: 10.1016/S1674-8301(10)60004-8.
3
In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice.
二脒那嗪与氯喹联合治疗小鼠内脏利什曼病的体外活性和体内疗效
J Biomed Res. 2015 May;29(3):214-23. doi: 10.7555/JBR.29.20140072. Epub 2015 Mar 4.
4
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.内脏利什曼病:通过经典和分子方法在疫苗开发方面的进展。
Front Immunol. 2014 Aug 22;5:380. doi: 10.3389/fimmu.2014.00380. eCollection 2014.
5
Development of Leishmania vaccines: predicting the future from past and present experience.利什曼原虫疫苗的研发:从过去和现在的经验预测未来
J Biomed Res. 2013 Mar;27(2):85-102. doi: 10.7555/JBR.27.20120064. Epub 2012 Sep 30.
Rev Inst Med Trop Sao Paulo. 2011 May-Jun;53(3):129-32. doi: 10.1590/s0036-46652011000300003.
4
Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice.基于 HSP70 和 HSP83 的疫苗制剂在感染杜氏利什曼原虫的 BALB/c 小鼠中的保护效力和免疫原性研究。
Acta Trop. 2011 Jul;119(1):50-6. doi: 10.1016/j.actatropica.2011.04.007. Epub 2011 Apr 21.
5
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.疫苗佐剂铝和单磷酰脂质 A 提供独特的信号来产生保护性细胞毒性记忆 CD8 T 细胞。
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7914-9. doi: 10.1073/pnas.1104588108. Epub 2011 Apr 25.
6
Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51.含疟疾原虫环子孢子蛋白衍生长合成肽的新型疫苗联合 Montanide ISA 720 或 Montanide ISA 51 佐剂的 I 期安全性和免疫原性临床试验
Am J Trop Med Hyg. 2011 Feb;84(2 Suppl):12-20. doi: 10.4269/ajtmh.2011.09-0516.
7
Vaccines for leishmaniasis: from proteome to vaccine candidates.利什曼病疫苗:从蛋白质组到候选疫苗
Hum Vaccin. 2011 Jan-Feb;7 Suppl:10-5. doi: 10.4161/hv.7.0.14556. Epub 2011 Jan 1.
8
Leishmaniasis vaccines: past, present and future.利什曼病疫苗:过去、现在和未来。
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S58-61. doi: 10.1016/j.ijantimicag.2010.06.024. Epub 2010 Aug 30.
9
Immunological perspectives of leishmaniasis.利什曼病的免疫学观点
J Glob Infect Dis. 2010 May;2(2):135-46. doi: 10.4103/0974-777X.62876.
10
Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae.BALB/c小鼠对与卡介苗或母牛分枝杆菌混合的明矾沉淀高压灭菌的硕大利什曼原虫(Alum-ALM)实验疫苗的免疫反应。
Trop Biomed. 2010 Apr;27(1):89-102.